1. Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers. Issue 16 (18th August 2020) Authors: Climax, John; Newsome, Philip N.; Hamza, Moayed; Weissbach, Markus; Coughlan, David; Sattar, Naveed; McGuire, Darren K.; Bhatt, Deepak L. Journal: Journal of the American Heart Association Issue: Volume 9:Issue 16(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗